A carregar...

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

PURPOSE: To investigate whether the relation between estrogen-progestagen menopausal hormone therapy (EP-MHT) and breast cancer risk varies according to the delay between menopause onset and treatment initiation. MATERIALS AND METHODS: Between 1992 and 2005, 1,726 invasive breast cancers were identi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Fournier, Agnès, Mesrine, Sylvie, Boutron-Ruault, Marie-Christine, Clavel-Chapelon, Françoise
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6413836/
https://ncbi.nlm.nih.gov/pubmed/19752341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.21.6432
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!